Laurie H. Glimcher Biography

Laurie H. Glimcher MD is the president and CEO of the Dana-Farber Cancer Institute a thorough malignancy treatment and examination focus in Boston Massachusetts. She is an individual from the Cancer Research Institute Prix Galien Parker Institute for Cancer Immunotherapy and Repair Therapeutics Scientific Advisory Boards the Lasker Award Jury the American Association for Cancer Research the Association of American Cancer Institutes and the American Society of Clinical Oncology. She is the prime supporter of Quentin Therapeutics. She recently served on the Board of Directors of the Bristol Myers Squibb pharmaceutical company and is at present on the Corporate Board of Directors of the GlaxoSmithKline pharmaceutical organization and the Waters Corporation. A pioneer in malignancy research Dr. Glimcher is commended for her exploration disclosures in the fields of transcriptional guideline lymphocyte separation immunology and osteobiology. As an immunologist, her essential examination interests are clarifying the atomic pathways that manage the insusceptible framework basic for both the advancement of defensive insusceptibility and for the pathophysiologic resistant reactions basic immune system irresistible and threatening sicknesses."

As a renowned expert and highly sought-after speaker, Laurie H. Glimcher's expertise is in high demand. To book Laurie H. Glimcher for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Laurie H. Glimcher's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Laurie H. Glimcher's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Laurie H. Glimcher for your next speaking engagement.